EODData

ASX, IVX: Invion Ltd.

18 Feb 2026
LAST:

0.0850

CHANGE:
 0.00
OPEN:
0.0850
HIGH:
0.0850
ASK:
0.1250
VOLUME:
0
CHG(%):
0.00
PREV:
0.0850
LOW:
0.0850
BID:
0.1200
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Feb 260.08500.08500.08500.08500
17 Feb 260.08500.08500.08500.0850125.0K
16 Feb 260.08100.08100.08100.08100
13 Feb 260.08400.08400.08100.0810190.0K
12 Feb 260.08400.08400.08400.0840200
11 Feb 260.08200.08300.08200.083074.6K
10 Feb 260.08700.08700.08200.083043.3K
09 Feb 260.08500.08500.08300.083074.2K
06 Feb 260.08800.08800.08400.085039.4K
05 Feb 260.08500.08500.08300.0830133.1K

PROFILE

Name:Invion Ltd.
About:Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Sector:Healthcare
Address:385 Bourke Street, Melbourne, VIC, Australia, 3000
Website:https://www.inviongroup.com
ISIN:AU000000IVX4
FIGI:BBG000PX9JQ0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.74 
Price to Sales:2,556.63 
Price to Book:0.94 
Operating Margin:-2,300.01 
Return on Assets:-0.44 
Return on Equity:-0.78 
EPS Ratio:-0.12 
Revenue:3.0K 
Shares:85.65M 
Market Cap:7.28M 

TECHNICAL INDICATORS

MA5:0.082.2%
MA10:0.082.0%
MA20:0.091.6%
MA50:0.094.7%
MA100:0.095.8%
MA200:0.1017.4%
STO9:57.14
STO14:36.36
RSI14:33.33 
WPR14:-63.64
MTM14:-0.01
ROC14:-0.08 
ATR:0.00 
Week High:0.090.0%
Week Low:0.084.9%
Month High:0.0910.6%
Month Low:0.0817.4%
Year High:0.20135.3%
Year Low:0.0813.3%
Volatility:14.08 

RECENT SPLITS

Date Ratio
19 Nov 20241-100